Human Hepatitis B Immunoglobulin (Shanxi Kangbao Biological)

乙型肝炎人免疫球蛋白（山西康宝生物）

Report date: 2026/01/20 10:19:43

Base Information

Drug NameHuman Hepatitis B Immunoglobulin (Shanxi Kangbao Biological)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date2019/03/06
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanxi Kangbao Biological Product Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanxi Kangbao Biological Product Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA01
Related LinksN/A